Hisco announced that it has obtained the “Drug Clinical Trial Approval Notice” for the new indication of the innovative drug HSK31858 tablets.
海思科：获得创新药HSK31858片新适应症《药物临床试验批准通知书》
HiCisco: Received the “Drug Clinical Trial Approval Notice” for the new indication of the innovative drug HSK31858 tablets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.